Literature DB >> 6388670

No narcosis for bone marrow harvest in autologous bone marrow transplantation.

E G de Vries, R Vriesendorp, A F Meinesz, N H Mulder, P E Postmus, D T Sleijfer.   

Abstract

A prospective study with mild general analgesia and sedation together with local anesthesia during bone marrow harvest was performed. Thirty-one patients underwent 33 bone marrow collections. Pretreatment consisted of 100 mg meperidine i.m. and 20 mg diazepam i.m. 1 h before start of procedure. Eight patients got additional meperidine and diazepam during the procedure, all patients got lidocaine 1% locally. A mean volume of 1.321 was obtained with 42.5 punctures. Twenty-two patients had no complications, 4 vomited, 4 had easily correctable hypotension of short duration, one got oxygen for cyanosis of short duration. Acceptance was good in 23 patients, in 6 reasonably well, in two bad. Only one patient experienced pain problems, due to suction. Anxiety was no major problem due to good information before the procedure and mild sedation. This form of anesthesia for bone marrow collection is a safe procedure, it is generally well accepted by the patient and it can be performed on an out-patient basis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6388670     DOI: 10.1007/bf00319890

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  3 in total

1.  Technique for human marrow grafting.

Authors:  E D Thomas; R Storb
Journal:  Blood       Date:  1970-10       Impact factor: 22.113

2.  Hepatotoxicity of chemotherapeutic agents.

Authors:  M C Perry
Journal:  Semin Oncol       Date:  1982-03       Impact factor: 4.929

3.  High-dose cytoreductive therapy with autologous bone marrow transplantation in advanced malignancies.

Authors:  A Barbasch; D J Higby; C Brass; K Bakri; C Karakousis; J E Pontes; L Z Wajsman; S Beckley; A Freeman; K Killion; D Burnett
Journal:  Cancer Treat Rep       Date:  1983-02
  3 in total
  2 in total

Review 1.  Anaesthetic implications for bone marrow transplant recipients.

Authors:  R A Stein; M J Messino; E A Hessel
Journal:  Can J Anaesth       Date:  1990-07       Impact factor: 5.063

2.  Granulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?

Authors:  Courtney D Fitzhugh; Matthew M Hsieh; Charles D Bolan; Carla Saenz; John F Tisdale
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.